Interventions for Health Promotion and Disease Prevention in Native American Populations (R01) 

The purpose of this funding opportunity announcement (FOA) is to develop, adapt, and test the effectiveness of health promotion and disease prevention interventions in Native American (NA) populations. NA populations are exposed to considerable risk factors that significantly increase their likelihood of chronic disease, substance abuse, mental illness, oral diseases, and HIV-infection. The intervention program should be culturally appropriate and promote the adoption of healthy lifestyles, improve behaviors and social conditions and/or improve environmental conditions related to chronic diseases, the consumption of tobacco, alcohol and other drugs, mental illness, oral disease, or HIV-infection. The intervention program should be designed so that it could be sustained within the entire community within existing resources, and, if successful, disseminated in other Native American communities. The long-term goal of this FOA is to reduce mortality and morbidity in NA communities. For the purposes of this FOA Native Americans include the following populations: Alaska Native, American Indian, and Native Hawaiian. The term Native Hawaiian means any individual any of whose ancestors were natives, prior to 1778, of the area which now comprises the State of Hawaii.

More information here. 

Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R34)

The purpose of this Funding Opportunity Announcement (FOA) is to encourage research applications to develop and pilot test approaches to improve diabetes and obesity prevention and/or treatment that are adapted for implementation in healthcare settings where individuals receive routine medical care. Research applications should be designed to pilot test practical and sustainable strategies to improve processes of care and health outcomes for individuals with or at risk of diabetes and/or obesity. The goal is that, if the pilot study shows promising results, the data from the R34 will be used to support a full-scale trial focused on improving routine healthcare practice and informing healthcare policy for the prevention or management of diabetes and obesity. 

Find more information here. 

Evaluating Natural Experiments in Healthcare to Improve Diabetes Prevention and Treatment (R18)

The purpose of this Research Demonstration and Dissemination Projects (R18) Funding Opportunity Announcement (FOA) is to support research to evaluate large scale policies or programs related to healthcare delivery that are expected to influence diabetes prevention and care. This FOA is not intended to support the initiation and delivery of new policies or programs. Research support is for the evaluation of the effectiveness of healthcare programs and/or policies implemented independent of NIH grant funding. The goal is to support research that meaningfully informs clinical practice and health policy related to prevention or management of diabetes.   

Find more information here. 

Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R18)

The purpose of this Funding Opportunity Announcement (FOA) is to encourage research applications to test innovative approaches to improve diabetes and obesity prevention and/or treatment that are adapted for implementation in healthcare settings where individuals receive their routine medical care. Research applications should be designed to test practical and sustainable strategies to improve processes of care and health outcomes for individuals with or at risk of diabetes and/or obesity. The research should also focus on approaches that can be broadly disseminated outside the specific setting where it is being tested. The goal of the research is to obtain results that will improve routine healthcare practice and inform healthcare policy for the prevention or management of these conditions. Therefore, interventions must be integrated into the existing healthcare structure and/or processes; the healthcare setting may not be used solely as a venue for recruitment.  

Find more information here. 

NIH Health Care Systems Research Collaboratory - Demonstration Projects for Pragmatic Clinical Trials (UG3/UH3)

The purpose of this FOA is to solicit applications to support Demonstration Projects that include an efficient, large-scale pragmatic clinical trial. Trials must be conducted across two or more health care systems (HCS) and must be conducted as part of the NIH HCS Research Collaboratory supported through the NIH Common Fund. (See https://commonfund.nih.gov/hcscollaboratory). Awards made through this FOA will initially support a one-year milestone-driven planning phase (UG3), with possible rapid transition to the second implementation phase (UH3) for a pragmatic trial Demonstration Project. UH3s will be awarded after administrative review of eligible UG3s that have met the scientific milestone and feasibility requirements necessary for the UH3 implementation phase, depending on the availability of funds. The UG3/UH3 application must be submitted as a single application, and applicants should note specific instructions for each phase in this FOA. 

The overall goal of the NIH HCS Research Collaboratory program is to strengthen the national capacity to implement cost-effective, large-scale research studies that engage health care delivery organizations as research partners. The NIH HCS Research Collaboratory Program has established a Collaboratory Coordinating Center (CCC) that is providing national leadership and technical expertise in all aspects of research with HCS.  After awards are made by NIH, the CCC (https://www.nihcollaboratory.org/Pages/default.aspx) and the NIH will work with successful awardees from this FOA to facilitate the planning and rapid execution of high impact Demonstration Projects that conduct research studies in partnerships with health care delivery systems, ultimately making available data, tools and resources from Collaboratory research projects to develop a broadened base of research partnerships with HCS.\

More info here: https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-16-019.html 

Addressing Health Disparities in NIDDK Diseases (R01)

There are many diseases and disorders that disproportionately affect the health of underserved populations in the United States. African-Americans, Hispanic Americans, American Indians, Alaska Natives, AsianAmericans, Native Hawaiians and other Pacific Islanders, and rural populations experience much higher risks of and poorer health status than the majority population. Several of the diseases that disproportionately afflict underserved populations are high priority research areas for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH).  The NIDDK seeks research to improve understanding of the causes of disparities in health and disability in the United States and reducing/eliminating health disparities directly related to the scientific areas within the mission of the NIDDK  http://www2.niddk.nih.gov/Research/ScientificAreas/default.htm.

For the purposes of this FOA, the following definitions are to be utilized by all applicants:

• Health Disparity: as defined by Healthy People 2020, is “a particular type of health difference that is closely linked with social, economic, and/or environmental disadvantage. Health disparities adversely affect groups of people who have systematically experienced greater obstacles to health based on their racial or ethnic group; religion; socioeconomic status; gender; age; mental health; cognitive, sensory, or physical disability; sexual orientation or gender identity; geographic location; or other characteristics historically linked to discrimination or exclusion.”
• Health Equity: as defined by Healthy People 2020, is the “attainment of the highest level of health for all people. Achieving health equity requires valuing everyone equally with focused and ongoing societal efforts to address avoidable inequalities, historical and contemporary injustices, and the elimination of health and health care disparities.”

Minority Health Populations:  Are defined by the Office of Management and Budget and include: African American or Black; Asian (>30 countries); American Indian or Alaska Native; Native Hawaiian or other Pacific Islander; and Latino or Hispanic (20 countries). 

More info here: https://grants.nih.gov/grants/guide/pa-files/PA-17-021.html 

Broad PCORI Funding Announcements

Broad PCORI Funding Announcements

The Broad PCORI Funding Announcements (PFAs) seek investigator-initiated applications for patient-centered comparative clinical effectiveness research (CER) projects aligned with our five priority areas for research. An announcement in each area is posted twice a year. We are looking for your best ideas to address needs of patients, caregivers, clinicians, and other healthcare stakeholders in making personalized clinical decisions across a wide range of conditions, populations, and treatments.

These broad areas encompass the patient-centered comparative clinical effectiveness research we support. As our work progresses and we engage with a broad range of patients, caregivers, clinicians, and other healthcare stakeholders, we may develop additional national priorities for research.

More information here. 

Improving Methods for Conducting PCOR

Improving Methods for Conducting Patient Centered Outcomes Research 

In this PCORI Funding Announcement (PFA), we seek to fund projects to address gaps in methodological research relevant to conducting patient-centered outcomes research (PCOR). The improvement of existing methods will benefit all stakeholders, including researchers planning investigations; policy makers weighing the value of healthcare interventions; and patients, clinicians, and caregivers facing healthcare decisions.

Letter of Intent due February 14th 

More information here. 

Health Economics and Policy Pilot Program

Center for Health Economics and Policy (CHEP) Pilot Program

Awards will be made for up to $30,000 direct costs for 1 year to facilitate the planning of a new health economics and/or policy research project. Pilot grants are used to fund developmental or early stage work, including pilot data and preparation for submission of a grant proposal or peer-reviewed publication.

Letter of intent due February 28th. 

Research Themes: Types of Studies Supported

This program is designed to support a broad range of health economics and policy studies including, but not limited to, the following themes and examples:

·         Implications of Change in Existing Programs or Guidelines Established by Federal/State Policies.  Identify strategies to most effectively, equitably, and efficiently modify existing health policies or develop new policies or provide improved health outcomes.

·         Improve Methods for Health Economics and Policy Research: Development and/or use of applicable datasets, measures, and analyses to measure outcomes of policy change or the development of new policy parameters. 

·         Improving Health Care Affordability, Efficiency, and Cost Transparency: Including topic areas of reducing cost growth, comparing performance of systems and providers, analyzing incentives interventions aimed at improving performance.

·         Increasing Accessibility to Health Care: Including improving access to providers, decreasing disparities in health care access, improving access to health insurance, and the effects of the ACA on access.

·         Identify Core Criteria for Successful Public Health Policies: Evaluate contextual and environmental factors that influence the success of public health policies.

·         Understand Resources or Costs for Implementation or Non-implementation of New or Modified Health Policies: Evaluate changes in existing or potential policies for providers, systems or communities.

·         Analyze Policy Development to Determine Cost-Effectiveness of the Intervention.

Find more information here.  

Looking for funding? Opportunities from the CDC and NIH

NIH Health Care Systems Research Collaboratory - Demonstration Projects for Pragmatic Clinical Trials (UG3/UH3)

               Posted: Nov 23. 1016

               Open: May 2, 2017

               Closed: June 2, 2017

               Agency Name: NIH 

Description: “The purpose of this FOA is to solicit applications to support Demonstration Projects that include an efficient, large-scale pragmatic clinical trial. Trials must be conducted across two or more health care systems (HCS) and must be conducted as part of the NIH HCS Research Collaboratory supported through the NIH Common Fund. (See https://commonfund.nih.gov/hcscollaboratory). Awards made through this FOA will initially support a one-year milestone-driven planning phase (UG3), with possible rapid transition to the second implementation phase (UH3) for a pragmatic trial Demonstration Project. UH3s will be awarded after administrative review of eligible UG3s that have met the scientific milestone and feasibility requirements necessary for the UH3 implementation phase, depending on the availability of funds. The UG3/UH3 application must be submitted as a single application, and applicants should note specific instructions for each phase in this FOA.

The overall goal of the NIH HCS Research Collaboratory program is to strengthen the national capacity to implement cost-effective, large-scale research studies that engage health care delivery organizations as research partners. The NIH HCS Research Collaboratory Program has established a Collaboratory Coordinating Center (CCC) that is providing national leadership and technical expertise in all aspects of research with HCS.  After awards are made by NIH, the CCC (https://www.nihcollaboratory.org/Pages/default.aspx) and the NIH will work with successful awardees from this FOA to facilitate the planning and rapid execution of high impact Demonstration Projects that conduct research studies in partnerships with health care delivery systems, ultimately making available data, tools and resources from Collaboratory research projects to develop a broadened base of research partnerships with HCS.”

More information HERE 

Community Characteristics Associated with Geographic Disparities in Diabetes and Cardiometabolic Health

                Posted: Dec 10, 2016

                Closed: Feb 14, 2017

                Agency Name: Centers for Disease Control and Prevention-ERA

Description: “This FOA has two components, A and B. Component A supports applications aimed at examination of county-level disparities in type 2 diabetes and cardiometabolic conditions to enhance understanding of disease determinants. Applicants will test hypotheses aimed at clarifying the contribution of environmental or socioeconomic circumstances to diabetes geographic disparities. As part of this initiative, Component A awardees will also be asked to form a common protocol and data management plan for the collection of a core set of exposure and outcome variables to permit multi-center analyses. Component B of this FOA solicits applications for a study Coordinating Center (CC) to provide logistics, data management, and analysis support to the multi-center research study.It is anticipated that 5 awards (4 for Component A and 1 for component B) will be made under this FOA. An institution (normally identified by having a unique DUNS number) may submit no more than one application for Component A and no more than one for component B. However, no institution will receive more than one award under this funding announcement; an awardee for Component B will not also receive an award for Component A.”

More information HERE 

 

Natural Experiments of Policy and Built Environment Impact on Diabetes Risk

                Posted: Dec 7, 2016

                Closed: Feb 13, 2017

                Agency Name: Centers for Disease Control and Prevention – ERA

Description: “This FOA has two components, A and B. Component A: To support a 5-year multi-center research network of innovative, non-health system-based, natural experiments approaches to alter the diabetogenic characteristics of US communities. Priority areas include population-level approaches to the promotion of healthy eating and active living by evaluating the impact of environmental and policy interventions on population-level risk factors for diabetes. Component B: To fund a Central Coordinating Center (CCC) to provide organizational, logistic and communication support to enhance the efficiency, productivity, and impact of the Natural Experiments research centers that are funded as part of Component A.”

More information HERE

Rural Policy Analysis Program (HRSA)

Additional Information:
http://www.grants.gov/web/grants/view-opportunity.html?oppId=285998

Description:
Eligible applicants include domestic public or private, non-profit or for-profit organizations. Eligible organizations may include State, local, and Indian tribal governments; institutions of higher education; other non-profit organizations (including faith-based, community-based, and tribal organizations); and hospitals. Eligible applicants must be national in scope and have well- established relationships with each of the following constituencies: rural clinical service networks; frontier residents; rural hospitals and community health systems; rural medical and health care provider educators; rural health clinics; State Rural Health Associations (SRHA) and State Offices of Rural Health (SORHs). You must have experience identifying emerging rural health care policy issues and promptly providing feedback to office inquiries regarding those issues.  Eligible applicants must demonstrate experience conducting policy research in the areas of access to health care services, Medicare and Medicaid policies, and development of rural delivery systems and public health. You should also have the capacity to quickly synthesize and disseminate policy analysis that informs policy makers of the needs of rural health care delivery systems in the design and implementation of health care policy.  Finally, you must demonstrate past experience in, and the ability to communicate results and implications of national health policy analyses for rural health services and delivery to a variety of audiences in a number of settings, including meeting presentations and panel discussions.  Applications that fail to show such experience will not be considered. 

Strategies to Increase Delivery of Guideline-Based Care to Populations with Health Disparities (R01)

Additional Information:
http://grants.nih.gov/grants/guide/pa-files/PAR-15-279.html

Description:
This Funding Opportunity Announcement (FOA) invites applications to conduct innovative and feasible studies to test strategies to accelerate the adoption of guideline-based recommendations into clinical practice among populations with health disparities.  Applications that propose strategies with a focus on providers who care for clinical populations with excess burden of cardiovascular, lung, blood, and sleep diseases and disorders, in concert with the health care delivery systems in which they practice, are strongly encouraged. Applications that test systems, infrastructures, and strategies to implement guideline-based care for NHLBI disorders in clinical care settings are also of high programmatic interest.

Training Institute for Dissemination and Implementation Research in Health

Additional Information:
http://www.scgcorp.com/tidirh2016/application.html

Description:
This training is designed for investigators at any career stage interested in conducting D&I research. To be eligible, participants must NOT have current R18, R01, or R01-equivalent funding as a principal investigator for D&I research and may not have received such funding in the past 5 years. Note: Investigators who have received an R01 or equivalent are eligible, as long as the funding was not specifically for D&I research. Preference will be given to applicants who demonstrate experience with—or potential for—working effectively in transdisciplinary teams and who have strong partnerships with—or are embedded within—health care delivery, public health, or community-based networks. We seek a balance of both junior and senior investigators, with the overall goal of bringing new people into the field of D&I research. While we anticipate most participants will be early- to mid-career individuals, we will enroll a limited number of senior researchers who are making the switch to D&I research. 

Development of the Gabriella Miller Kids First Pediatric Data Resource Center (U2C)

Additional Information:
http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-16-010.html

Description:
The objective of this FOA is to support the development of the Data Resource Center for the Gabriella Miller Kids First Pediatric Research Program (Kids First), which consists of the following components: a web-based Data Resource Portal, a Data Coordination Center, and Administrative and Outreach Core.  The goal of the Data Resource Portal is to accelerate discovery of genetic etiology and shared biologic pathways within and across childhood cancers and structural birth defects by facilitating access to and querying of annotated genomic sequence and phenotypic data from cohorts of patients with these conditions.  The Data Resource Portal will serve as an indispensable research resource where genomic data can be aggregated, accessed, analyzed, and shared within and across the childhood cancer and birth defects research communities as well as the broader scientific community.  The Data Coordination Center will work with Kids First investigators and sequencing centers to facilitate data collection and harmonization.  The Administrative and Outreach Core will oversee administrative activities, work closely with a Steering Committee, and provide outreach and education to the research community on using the Data Resource Portal.

Rural Health Research Dissemination

Additional Information:
http://www.grants.gov/web/grants/view-opportunity.html?oppId=284893

Description:
The purpose of the Rural Health Research Dissemination Program is to disseminate and market policy-oriented information for use by diverse audiences such as rural stakeholders at national, state, and community levels and policy decision-makers to inform and raise awareness of issues regarding policy implications, access, quality and status of health care delivery, services, and management on behalf of rural communities.

Rural Policy Analysis Program

Additional Information:
http://www.grants.gov/web/grants/view-opportunity.html?oppId=284897

Description:
The purpose of this program is to support research syntheses and analyses of specific rural health issues that affect rural communities.  Issue areas are expected to be of national interest, and may include cross-cutting rural health and human services dimensions.  Products, including reports and Policy Briefs, will support policy-makers, and policy development and implementation; each product will summarize an issue, related health policies, and identify implications and next steps relevant to rural stakeholders.

Children's Discovery Institute Call for Proposals

Additional Information:
https://research.wustl.edu/researchnews/BulletinAttachments/2017%20Call%20for%20Proposals%20-%20Fall%20Cycle.pdf

Description:

Funding Objectives:



Preference will be given to faculty members prior to

achieving tenure, to teams of investigators from

multiple disciplines, and to multi-investigator projects to develop interactive research groups.



Translational impact, scientific excellence, and potential for acquisition of new knowledge. This

includes the development and/or testing of novel appr

oaches for diagnosis, therapy and/or prevention.



Programs synergistic with Washington Univ

ersity and St. Louis Children’s Hospital.



Immediate relevance to goals of one or more of the CDI’s Centers:

o

McDonnell Pediatric Cancer Center focuses on the etiology and treatment of pediatric

cancers.

o

Center for Metabolism and Immunity focuses on musculoskeletal, kidney and

gastrointestinal disorders including the microbiome, disorders of metabolism, and diseases

related to the immune system.

o

Center for Pediatric Pulmonary Disease focuses on the biology of the pulmonary system

and genetic and acquired causes of pediatric lung disease.

o

Congenital Heart Disease Center focuses on

the environmental and genetic etiology of

congenital heart and vascular disease, related birth defects, and other heart disorders.

Office of Elementary and Secondary Education (OESE): Office of Indian Education (OIE): Indian Education Discretionary Grants Programs: Professional Development Grants Program

Additional Information:
http://www.grants.gov/web/grants/view-opportunity.html?oppId=283906

Description:
Each funding opportunity description is a synopsis of information in the Federal Register application notice. For specific information about eligibility, please see the official application notice. The official version of this document is the document published in the Federal Register. Free Internet access to the official edition of the Federal Register and the Code of Federal Regulations is available on GPO Access at: http://www.access.gpo.gov/nara/index.html. Please review the official application notice for pre-application and application requirements, application submission information, performance measures, priorities and program contact information. Purpose of Program: The purposes of the Indian Education Professional Development Grants program are to (1) increase the number of qualified Indian individuals in professions that serve Indians; (2) provide training to qualified Indian individuals to become teachers, administrators, teacher aides, social workers, and ancillary educational personnel; and (3) improve the skills of qualified Indian individuals who serve in the education field. Catalog of Federal Domestic Assistance (CFDA) Number: 84.299B. Applications for grants under the Indian Education--Professional Development Grants program, CFDA number 84.299B, must be submitted electronically using the Governmentwide Grants.gov Apply site at www.Grants.gov. Through this site, you will be able to download a copy of the application package, complete it offline, and then upload and submit your application. You may not email an electronic copy of a grant application to us. You may access the electronic grant application for the Indian Education_Professional Development Grants program at www.Grants.gov. You must search for the downloadable application package for this program by the CFDA number. Do not include the CFDA number's alpha suffix in your search (e.g., search for 84.299, not 84.299B).

Dissemination and Implementation Research in Health (R01, R21, and R03)

Additional Information:
R01: http://grants.nih.gov/grants/guide/pa-files/PAR-16-238.html
R21: http://grants.nih.gov/grants/guide/pa-files/PAR-16-236.html
R03: http://grants.nih.gov/grants/guide/pa-files/PAR-16-237.html

Description:
This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices (e.g. behavioral interventions; prevention, early detection, diagnostic, treatment and disease management interventions; quality improvement programs) into public health, clinical practice, and community settings. In addition, studies to advance dissemination and implementation research methods and measures are encouraged.  

Native American Research Centers for Health (NARCH) (S06)

Additional Information:
http://grants.nih.gov/grants/guide/pa-files/PAR-16-297.html

Description:
The purpose of this funding opportunity announcement (FOA) is to encourage grant applications for new or continued Native American Research Centers for Health (NARCH). The NARCH program supports opportunities for conducting research and  career enhancement to meet the health needs of American Indian/Alaska Native (AI/AN) communities and the scientists conducting research on the health needs of these communities. This FOA is issued by the National Institute of General Medical Sciences in conjunction with the other Institutes/Centers of the National Institutes of Health (NIH) and the Indian Health Service (IHS).